981 related articles for article (PubMed ID: 34534764)
21. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
22. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
Hanafy AS; Lamprecht A; Dietrich D
Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886
[TBL] [Abstract][Full Text] [Related]
23. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
24. Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease.
Polis B; Gurevich V; Assa M; Samson AO
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540372
[TBL] [Abstract][Full Text] [Related]
25. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
[TBL] [Abstract][Full Text] [Related]
27. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
28. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.
Cao Y; Xu H; Zhu Y; Shi MJ; Wei L; Zhang J; Cheng S; Shi Y; Tong H; Kang L; Lu L; Luo H; Yang X; Bai X; Wang R; Ma Y; Wang Y; Wang Z; Zhong K; Zhao BQ; Fan W
PLoS Biol; 2019 Jun; 17(6):e3000313. PubMed ID: 31185010
[TBL] [Abstract][Full Text] [Related]
32. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
33. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach.
Li S; Wang C; Wang Z; Tan J
Aging (Albany NY); 2021 Sep; 13(17):21791-21806. PubMed ID: 34479211
[TBL] [Abstract][Full Text] [Related]
35. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.
Kumar-Singh S; Pirici D; McGowan E; Serneels S; Ceuterick C; Hardy J; Duff K; Dickson D; Van Broeckhoven C
Am J Pathol; 2005 Aug; 167(2):527-43. PubMed ID: 16049337
[TBL] [Abstract][Full Text] [Related]
36. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
Provias J; Jeynes B
Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
[TBL] [Abstract][Full Text] [Related]
37. Brain capillaries in Alzheimer's disease.
Baloyannis SJ
Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
[TBL] [Abstract][Full Text] [Related]
38. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
39. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.
Zhang M; Zhang Z; Li H; Xia Y; Xing M; Xiao C; Cai W; Bu L; Li Y; Park TE; Tang Y; Ye X; Lin WJ
Transl Neurodegener; 2024 Jan; 13(1):1. PubMed ID: 38173017
[TBL] [Abstract][Full Text] [Related]
40. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
